A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has unveiled a hemolysis-free and highly efficient blood plasma separation platform.

Plasma from COVID-19 survivors may help treat patients who are critically ill with the virus. Getty Images By now, you've heard a lot of talk about antibodies and antibody tests when it comes to ...

Hemolysis also can occur during blood work when blood is drawn too quickly through a needle, ... The plasma is naturally conductive and is efficient at passing an electric charge.

Vivid plasma separation membranes are optimized for one-step plasma separation from whole blood without the need for centrifugation. Whole blood processed through the Vivid plasma separation membrane ...

Hemolysis is the destruction of red blood cells (RBCs). Typically, RBCs can live for up to 120 days before the body naturally destroys them. However, certain conditions and medications may cause ...

Identify data and insights on the impact of hemolysis in whole blood potassium testing; Outline the specific patient care impact of hemolysis in emergency and neonatal care; Discuss the experience of ...

However, the integrity of samples collected in these tubes often suffers during the collection, transportation, and processing stages. Novel BCTs can now maintain the draw-time concentrations of ...

To manage patients’ hemolysis, 68% (n = 13) underwent a dose increase of pegcetacoplan from twice weekly to 1080 mg every 3 days. This approach reportedly benefited 6 patients’ hemolytic outcomes.

The highly asymmetric nature of Vivid plasma separation (PS) membranes allow the cellular components of the blood (red cells, white cells and platelets) to be captured in the larger pores without ...